1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Tarsus Pharmaceuticals Inc (TARS)
  7. Quote


Tarsus Pharmaceuticals Stock Price

-1.46 (-5.03%)
Volume 27,408
Bid Price 21.20
Ask Price 60.00
News -
Day High 29.08


52 Week Range


Day Low 27.2035
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Tarsus Pharmaceuticals Inc TARS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.46 -5.03% 27.54 18:00:16
Open Price Low Price High Price Close Price Prev Close
29.07 27.2035 29.08 27.54 29.00
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,214 27,408 $ 27.85 $ 763,324 - 17.96 - 63.69
Last Trade Time Type Quantity Stock Price Currency
16:35:24 formt 140 $ 27.54 USD


Draw Mode:

Tarsus Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 566.61M 20.57M 8.84M $ - $ - -4.52 -8.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -5.93k 7.50%

more financials information »

Tarsus Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TARS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week28.9529.4426.4828.2130,853-1.41-4.87%
1 Month22.7030.999921.0026.8134,2264.8421.32%
3 Months23.5030.999921.0025.2229,1974.0417.19%
6 Months32.7439.0821.0028.7850,129-5.20-15.88%
1 Year21.8063.6917.9633.4758,6935.7426.33%
3 Years18.3063.6917.9632.9660,1819.2450.49%
5 Years18.3063.6917.9632.9660,1819.2450.49%

Tarsus Pharmaceuticals Description

Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites.

Your Recent History
Tarsus Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.